We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
PURITAN MEDICAL

Download Mobile App




Sweat Chloride Quantified Using Capillary Electrophoresis

By LabMedica International staff writers
Posted on 18 Feb 2019
Cystic fibrosis (CF) is the less rare and severe genetic disease among the European population. More...
Biochemical diagnosis of CF is based on the demonstration of increased chloride concentration in sweat samples, obtained during the sweat test (ST).

Capillary electrophoresis (CE) is able to directly measure chloride. CE is already known as a high performance separation technique, quick and a low-sample volume consumer/user, for and with different matrixes. This method has been shown as a useful tool for analysis of sweat chloride.

Scientists at the Hôpital Purpan (Toulouse, France) and their colleagues carried out a study on subjects referred to our laboratory for a ST between May and August 2017. During this period, a total of 65 sweat samples were processed for the diagnosis or for the initiation or follow-up of a new treatment. The mean age of all 48 subjects was 9.8 ± 10.7 years; median 5 (ranging from 0.1 to 58) years. The sweat induction was carried out by pilocarpine iontophoresis, the gold standard, with Webster Sweat Inducer. Then sweat was collected during 25 minutes with Macroduct collector.

The team used the ELITech Wescor ChloroChek Chloridometer test system, model 3400, to measure the chloride in human sweat using the principle of coulometric titration. This assay required at least 10 µL of sweat and provided a digital readout in mmol/L. A comparison test was performed with a capillary electrophoresis with contactless conductivity detection system (CE-C4D). This assay required only 2 µL.

The investigators reported that the concentration of sweat chloride, determined by coulometry, allowed them to distinguish three groups of patients, according to the new consensus guideline: (i) control group of 44 with chloride less than 30 mmol/L; three subjects as borderline group with chloride between 30 and 59 mmol/L; and a CF group of 18 with chloride equal to or greater than 60 mmol/L. The method validation showed comparable analytical performances for both methods; no false positive or false negative was recorded. The two methods showed a high correlation and a close agreement was demonstrated by two different statistical tests.

The authors concluded that WynSep CE is an accurate, fast, easy-to-use method and an appropriate technique for CF diagnosis. The WynSep CE device also offers a strong financial advantage, and as it is not dedicated to only sweat chloride assay and can be used for measurement of a variety of analytes. The study was published in the January 2019 issue of the journal Practical Laboratory Medicine.

Related Links:
Hôpital Purpan



Gold Member
Troponin T QC
Troponin T Quality Control
3-Part Differential Hematology Analyzer
Swelab Alfa Plus Sampler
New
Automated PCR Setup
ESTREAM
New
DNA/RNA Extraction/Purification Kit
Nucleic Acid Extraction or Purification Kit
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








DIASOURCE (A Biovendor Company)

Channels

Hematology

view channel
Image: CitoCBC is the world first cartridge-based CBC to be granted CLIA Waived status by FDA (Photo courtesy of CytoChip)

Disposable Cartridge-Based Test Delivers Rapid and Accurate CBC Results

Complete Blood Count (CBC) is one of the most commonly ordered lab tests, crucial for diagnosing diseases, monitoring therapies, and conducting routine health screenings. However, more than 90% of physician... Read more

Immunology

view channel
Image: An “evolutionary” approach to treating metastatic breast cancer could allow therapy choices to be adapted as patients’ cancer changes (Photo courtesy of 123RF)

Evolutionary Clinical Trial to Identify Novel Biomarker-Driven Therapies for Metastatic Breast Cancer

Metastatic breast cancer, which occurs when cancer spreads from the breast to other parts of the body, is one of the most difficult cancers to treat. Nearly 90% of patients with metastatic cancer will... Read more

Pathology

view channel
Image: A real-time trial has shown that AI could speed cancer care (Photo courtesy of Campanella, et al., Nature Medicine)

AI Accurately Predicts Genetic Mutations from Routine Pathology Slides for Faster Cancer Care

Current cancer treatment decisions are often guided by genetic testing, which can be expensive, time-consuming, and not always available at leading hospitals. For patients with lung adenocarcinoma, a critical... Read more

Technology

view channel
Image: Researchers Dr. Lee Eun Sook and Dr. Lee Jinhyung examine the imprinting equipment used for nanodisk synthesis (Photo courtesy of KRISS)

Multifunctional Nanomaterial Simultaneously Performs Cancer Diagnosis, Treatment, and Immune Activation

Cancer treatments, including surgery, radiation therapy, and chemotherapy, have significant limitations. These treatments not only target cancerous areas but also damage healthy tissues, causing side effects... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.